Free Trial

Cross Country Healthcare, Inc. (NASDAQ:CCRN) Shares Sold by Pinnacle Associates Ltd.

Cross Country Healthcare logo with Business Services background

Pinnacle Associates Ltd. decreased its position in Cross Country Healthcare, Inc. (NASDAQ:CCRN - Free Report) by 10.8% during the second quarter, according to the company in its most recent disclosure with the SEC. The firm owned 297,819 shares of the business services provider's stock after selling 35,924 shares during the quarter. Pinnacle Associates Ltd. owned approximately 0.86% of Cross Country Healthcare worth $4,122,000 at the end of the most recent quarter.

A number of other institutional investors also recently bought and sold shares of the company. GAMMA Investing LLC purchased a new stake in Cross Country Healthcare in the fourth quarter worth about $28,000. Gladius Capital Management LP increased its position in Cross Country Healthcare by 37.1% in the fourth quarter. Gladius Capital Management LP now owns 1,902 shares of the business services provider's stock worth $43,000 after buying an additional 515 shares in the last quarter. Denali Advisors LLC increased its position in Cross Country Healthcare by 3,885.5% in the first quarter. Denali Advisors LLC now owns 5,500 shares of the business services provider's stock worth $103,000 after buying an additional 5,362 shares in the last quarter. EMC Capital Management purchased a new stake in Cross Country Healthcare in the first quarter worth about $155,000. Finally, Bayesian Capital Management LP purchased a new stake in Cross Country Healthcare in the first quarter worth about $195,000. Institutional investors own 96.03% of the company's stock.

Analyst Ratings Changes

A number of brokerages have commented on CCRN. Barrington Research reduced their price target on Cross Country Healthcare from $21.00 to $19.00 and set an "outperform" rating for the company in a research report on Thursday, August 8th. Truist Financial upped their price target on Cross Country Healthcare from $16.00 to $17.00 and gave the stock a "hold" rating in a research report on Thursday, August 1st. Five investment analysts have rated the stock with a hold rating and two have issued a buy rating to the company's stock. According to MarketBeat, the stock presently has a consensus rating of "Hold" and an average price target of $19.60.


Read Our Latest Stock Report on CCRN

Insider Buying and Selling at Cross Country Healthcare

In other Cross Country Healthcare news, insider Karen Mote sold 13,829 shares of the firm's stock in a transaction that occurred on Friday, August 2nd. The stock was sold at an average price of $17.08, for a total transaction of $236,199.32. Following the completion of the transaction, the insider now owns 24,696 shares in the company, valued at approximately $421,807.68. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. In other news, VP Cynthia Ann Grieco sold 1,945 shares of the firm's stock in a transaction that occurred on Friday, August 2nd. The stock was sold at an average price of $17.21, for a total value of $33,473.45. Following the completion of the sale, the vice president now directly owns 7,605 shares of the company's stock, valued at approximately $130,882.05. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Karen Mote sold 13,829 shares of the firm's stock in a transaction that occurred on Friday, August 2nd. The shares were sold at an average price of $17.08, for a total value of $236,199.32. Following the completion of the sale, the insider now directly owns 24,696 shares of the company's stock, valued at $421,807.68. The disclosure for this sale can be found here. 4.90% of the stock is currently owned by company insiders.

Cross Country Healthcare Price Performance

Shares of NASDAQ:CCRN traded down $0.19 during trading on Friday, hitting $14.92. 333,721 shares of the company's stock were exchanged, compared to its average volume of 431,653. Cross Country Healthcare, Inc. has a 52-week low of $12.87 and a 52-week high of $26.17. The business's 50-day simple moving average is $14.90 and its 200 day simple moving average is $16.11. The company has a market cap of $518.83 million, a price-to-earnings ratio of 11.48, a PEG ratio of 2.57 and a beta of 0.63.

Cross Country Healthcare (NASDAQ:CCRN - Get Free Report) last released its quarterly earnings results on Wednesday, July 31st. The business services provider reported $0.10 earnings per share for the quarter, missing the consensus estimate of $0.14 by ($0.04). The firm had revenue of $339.77 million for the quarter, compared to analysts' expectations of $334.75 million. Cross Country Healthcare had a net margin of 0.54% and a return on equity of 7.29%. The business's quarterly revenue was down 37.2% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.69 EPS. On average, sell-side analysts anticipate that Cross Country Healthcare, Inc. will post 0.68 EPS for the current fiscal year.

About Cross Country Healthcare

(Free Report)

Cross Country Healthcare, Inc provides talent management and other consultative services for healthcare clients in the United States. The company's Nurse and Allied Staffing segment provides traditional staffing, recruiting, and value-added total talent solutions, including temporary and permanent placement of travel and local nurse and, allied professionals; temporary placement of healthcare leaders within nursing, allied, physician, and human resources; vendor neutral and managed services programs; education healthcare services; in-home care services; and outsourcing services.

Featured Stories

Institutional Ownership by Quarter for Cross Country Healthcare (NASDAQ:CCRN)

→ Forget Trump and Kamala (From Investors Alley) (Ad)

Should you invest $1,000 in Cross Country Healthcare right now?

Before you consider Cross Country Healthcare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cross Country Healthcare wasn't on the list.

While Cross Country Healthcare currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Is Palantir Heading for a $50 Price Target?
Rate Cuts Fuel Volatility: How Long Could it Last?
SMCI Stock: Is a Rebound Coming?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines